A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/48 (2006.01) A61K 31/00 (2006.01) A61K 38/00 (2006.01) A61K 38/16 (2006.01) A61P 21/00 (2006.01) C12N 9/48 (2006.01)
Patent
CA 2516745
Botulinum toxin, or other neuromuscular inhibitors, injected into the lower leg muscle of infants, less than a year old, with idiopathic clubfoot is shown to be an effective therapy in correcting this physical deformity. Following a protocol of manipulations, castings, and injections, clubfoot is effectively treated, and surgical treatment procedures can be avoided.
Allergan Inc.
Gowling Lafleur Henderson Llp
The University Of British Columbia
LandOfFree
Botulinum toxin in treatment of clubfoot relapse does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Botulinum toxin in treatment of clubfoot relapse, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Botulinum toxin in treatment of clubfoot relapse will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1711286